翰森制药(03692)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

03692 翰森制药

休市中 04-25 16:08:23

23.900

-0.350

-1.44%

最高24.850	最低23.700	成交量1,096万
今开24.750	昨收24.250	日振幅4.74%
总市值1,421亿	流通市值1,421亿	总股本59.47亿
成交额2.64亿	换手率0.18%	流通股本59.47亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"03692","market":"HK","secType":"STK","nameCN":"翰森制药","latestPrice":23.9,"timestamp":1745568503018,"preClose":24.25,"halted":0,"volume":10959657,"delay":0,"floatShares":5947000000,"shares":5947000000,"eps":0.7848159068175999,"marketStatus":"休市中","change":-0.35,"latestTime":"04-25 16:08:23","open":24.75,"high":24.85,"low":23.7,"amount":263634977,"amplitude":0.047423,"askPrice":23.95,"askSize":60000,"bidPrice":23.9,"bidSize":66000,"shortable":3,"etf":0,"ttmEps":0.7822875942259498,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1745803800000},"marketStatusCode":7,"adr":0,"listingDate":1560441600000,"exchange":"SEHK","adjPreClose":24.25,"dividendRate":0.01408,"openAndCloseTimeList":[[1745544600000,1745553600000],[1745557200000,1745568000000]],"volumeRatio":1.0148906339740333,"lotSize":2000,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/03692","defaultTab":"news","newsList":[{"id":"2530891139","title":"翰森制药(03692)：恒美达® (枸橼酸艾瑞芬净片)获国家药品监督管理局签发药品注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2530891139","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2530891139?lang=zh_cn&edition=full","pubTime":"2025-04-25 21:30","pubTimestamp":1745587836,"startTime":"0","endTime":"0","summary":"智通财经APP讯，翰森制药(03692)公布，恒美达® (枸橼酸艾瑞芬净片)获中国国家药品监督管理局(NMPA) 签发的药品注册证书，用于成年和初潮后青少年女性的外阴阴道念珠菌病(VVC) 的治疗。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1285429.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["03692","BK1191","BK1583","BK1589"],"gpt_icon":0},{"id":"2530903902","title":"翰森制药04月25日遭主力抛售299万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2530903902","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2530903902?lang=zh_cn&edition=full","pubTime":"2025-04-25 16:16","pubTimestamp":1745568975,"startTime":"0","endTime":"0","summary":"04月25日, 翰森制药股价跌1.44%，报收23.90元，成交金额2.64亿元，换手率0.18%，振幅4.74%，量比1.01。翰森制药今日主力资金净流出299万元，上一交易日主力净流出923万元。该股近5个交易日上涨10.30%，主力资金累计净流出998万元；近20日主力资金累计净流入2.87亿元，其中净流入天数为12日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250425170444a466929a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250425170444a466929a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","BK1589","03692","BK1583"],"gpt_icon":0},{"id":"2529261892","title":"翰森制药盘中异动 早盘股价大涨3.16%报24.500港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2529261892","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529261892?lang=zh_cn&edition=full","pubTime":"2025-04-24 09:41","pubTimestamp":1745458910,"startTime":"0","endTime":"0","summary":"2025年04月24日早盘09时41分，翰森制药股票出现波动，股价急速上涨3.16%。截至发稿，该股报24.500港元/股，成交量122.56万股，换手率0.02%，振幅3.37%。资金方面，该股资金流入1568.19万港元，流出779.11万港元。翰森制药股票所在的药品行业中，整体涨幅为0.27%。其相关个股中，凯莱英、信达生物、和黄医药涨幅较大，振幅较大的相关个股有凯莱英、信达生物、康龙化成，振幅分别为9.37%、5.64%、4.55%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250424094150aa2c7962&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250424094150aa2c7962&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1583","03692","BK1191","BK1589"],"gpt_icon":0},{"id":"2529784385","title":"翰森制药04月23日主力净流入97万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2529784385","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529784385?lang=zh_cn&edition=full","pubTime":"2025-04-23 16:15","pubTimestamp":1745396120,"startTime":"0","endTime":"0","summary":"04月23日, 翰森制药股价涨0.21%，报收23.75元，成交金额2.77亿元，换手率0.20%，振幅3.80%，量比1.01。翰森制药今日主力资金净流入97万元，上一交易日主力净流出59万元。该股近5个交易日上涨5.26%，主力资金累计净流入8121万元，其中2个交易日为股价下跌时净流入；近20日主力资金累计净流入2.97亿元，其中净流入天数为12日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250423170437a6c4f00a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250423170437a6c4f00a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1589","BK1191","BK1583","03692"],"gpt_icon":0},{"id":"2529374361","title":"翰森制药(03692)4月22日根据受限制股份单位计划发行1150万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2529374361","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529374361?lang=zh_cn&edition=full","pubTime":"2025-04-22 19:03","pubTimestamp":1745319815,"startTime":"0","endTime":"0","summary":"智通财经APP讯，翰森制药(03692)发布公告，该公司于2025年4月22日根据公司于2019年5月27日批准及采纳的受限制股份单位的计划发行1150万股公司股份。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1282399.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1191","03692","BK1583","BK1589"],"gpt_icon":0},{"id":"2529393901","title":"港股异动 | 翰森制药(03692)涨近6% 1类新药HS-10529片获批临床 拟开发治疗KRAS G12D突变晚期实体瘤","url":"https://stock-news.laohu8.com/highlight/detail?id=2529393901","media":"智通财经","labels":["productRelease","movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529393901?lang=zh_cn&edition=full","pubTime":"2025-04-22 10:29","pubTimestamp":1745288979,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，翰森制药涨近6%，截至发稿，涨5.88%，报23.4港元，成交额1.34亿港元。其中，翰森制药1类新药HS-10529片获批临床，拟开发治疗KRAS G12D突变的晚期实体瘤。根据翰森制药新闻稿介绍，这是该公司研发的一种靶向KRAS G12D的小分子抑制剂，具有高度选择性。临床前药效试验表明，HS-10529具有良好的临床前药效活性、药代动力学特征和安全性。此外，翰森制药还有另外两款1类新药首次在中国获批IND，但尚未从公开渠道查询到该产品的具体作用机制。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1282062.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"港股异动 | 翰森制药(03692)涨近6% 1类新药HS-10529片获批临床 拟开发治疗KRAS G12D突变晚期实体瘤","news_tag":"productRelease,movement","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1583","BK1191","03692","BK1589"],"gpt_icon":0},{"id":"2529397033","title":"翰森制药盘中异动 急速拉升3.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2529397033","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529397033?lang=zh_cn&edition=full","pubTime":"2025-04-22 09:30","pubTimestamp":1745285435,"startTime":"0","endTime":"0","summary":"2025年04月22日早盘09时30分，翰森制药股票出现异动，股价大幅上涨3.17%。截至发稿，该股报22.800港元/股，成交量44.67万股，换手率0.01%，振幅3.85%。翰森制药股票所在的药品行业中，整体涨幅为0.21%。其相关个股中，三生制药、信达生物、绿叶制药涨幅较大，振幅较大的相关个股有信达生物、三生制药、翰森制药，振幅分别为4.13%、4.01%、3.85%。翰森制药公司简介：翰森制药集团有限公司是一家主要从事一系列药品的研发、生产及销售的投资控股公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250422093035973ff6e4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250422093035973ff6e4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1583","03692","BK1589","BK1191"],"gpt_icon":0},{"id":"2529844068","title":"晚期实体瘤药物喜讯不断，人福医药、汇宇制药、翰森制药等多药企获批临床试验","url":"https://stock-news.laohu8.com/highlight/detail?id=2529844068","media":"动脉网","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529844068?lang=zh_cn&edition=full","pubTime":"2025-04-21 14:21","pubTimestamp":1745216460,"startTime":"0","endTime":"0","summary":"多家药企在晚期实体瘤药物研发方面取得进展，人福医药、汇宇制药、翰森制药等新药获批临床试验，为治疗带来新希望。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042114361494dc8a64&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042114361494dc8a64&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","BK1589","BK1583","03347","BK1576","03692","BK1141"],"gpt_icon":0},{"id":"2528023386","title":"10款1类新药首次在中国获批临床！来自翰森制药(03692)等","url":"https://stock-news.laohu8.com/highlight/detail?id=2528023386","media":"智通财经网","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2528023386?lang=zh_cn&edition=full","pubTime":"2025-04-19 10:04","pubTimestamp":1745028299,"startTime":"0","endTime":"0","summary":"这些产品涵盖了小分子、抗体偶联药物（ADC）、基因疗法、细胞疗法等类型，拟定适应症涵盖晚期实体瘤、1型糖尿病、脊髓损伤，以及杜氏肌营养不良（DMD）、阵发性睡眠性血红蛋白尿症等。","market":"hk","thumbnail":"https://img.zhitongcaijing.com/image/20250419/20250419100649_14463.png?x-oss-process=image/format,jpg/quality,q_60","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/image/20250419/20250419100649_14463.png?x-oss-process=image/format,jpg/quality,q_60"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1281126.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"10款1类新药首次在中国获批临床！来自翰森制药(03692)等","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["BK1191","03692","BK1583","BK1589"],"gpt_icon":1},{"id":"2528719036","title":"翰森制药(03692)：B7-H3靶向抗体-药物偶联物HS-20093用于非鳞状非小细胞肺癌获国家药监局纳入突破性治疗药物","url":"https://stock-news.laohu8.com/highlight/detail?id=2528719036","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2528719036?lang=zh_cn&edition=full","pubTime":"2025-04-17 20:16","pubTimestamp":1744892176,"startTime":"0","endTime":"0","summary":"于2024年11月1日，HS-20093用于经标准一线治疗后进展的广泛期小细胞肺癌适应症已被NMPA纳入突破性治疗药物。于2025年2月25日，HS-20093用于治疗经至少二线治疗后进展的骨肉瘤患者适应症已被NMPA纳入突破性治疗药物。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1280357.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1589","BK1583","BK1191","03692"],"gpt_icon":0},{"id":"2528966677","title":"翰森制药04月17日获主力加仓184万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2528966677","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2528966677?lang=zh_cn&edition=full","pubTime":"2025-04-17 16:15","pubTimestamp":1744877738,"startTime":"0","endTime":"0","summary":"04月17日, 翰森制药股价涨1.14%，报收22.10元，成交金额1.22亿元，换手率0.09%，振幅2.06%，量比0.41。翰森制药今日主力资金（超大单+大单）净流入184万元，上一交易日主力净流入2493万元。|04月17日主力加仓幅度排名||#|股票简称|主力净额占比|#|积木集团|1.93%|#|阳光纸业|1.51%|#|中国宏光|1.35%|#|...|...|#359|翰森制药|0.00%|（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250417170110a6bdb42e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250417170110a6bdb42e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","03692","BK1583","BK1589"],"gpt_icon":0},{"id":"2527228466","title":"翰森制药盘中异动 早盘大幅下挫3.16%报21.450港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2527228466","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2527228466?lang=zh_cn&edition=full","pubTime":"2025-04-16 11:10","pubTimestamp":1744773049,"startTime":"0","endTime":"0","summary":"2025年04月16日早盘11时10分，翰森制药股票出现波动，股价急速跳水3.16%。截至发稿，该股报21.450港元/股，成交量400.2万股，换手率0.07%，振幅3.16%。资金方面，该股资金流入4761.6万港元，流出3467.38万港元。翰森制药股票所在的药品行业中，整体跌幅为0.52%。其相关个股中，三爱健康集团、兴科蓉医药、顺腾国际控股涨幅较大，振幅较大的相关个股有培力农本方、顺腾国际控股、君圣泰医药-B，振幅分别为10.20%、8.33%、7.55%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025041611104994d6ddcc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025041611104994d6ddcc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1583","03692","BK1589","BK1191"],"gpt_icon":0},{"id":"2527117394","title":"翰森制药(03692)：HS-10529片获国家药品监督管理局签发的药物临床试验批准通知书","url":"https://stock-news.laohu8.com/highlight/detail?id=2527117394","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2527117394?lang=zh_cn&edition=full","pubTime":"2025-04-15 21:16","pubTimestamp":1744722983,"startTime":"0","endTime":"0","summary":"智通财经APP讯，翰森制药(03692)发布公告，集团自主研发的靶向KRAS G12D小分子1类新药HS-10529片获中国国家药品监督管理局(NMPA)签发的药物临床试验批准通知书，拟开展用于KRAS G12D突变的晚期实体瘤(胰腺癌、结直肠癌、非小细胞肺癌等)的临床试验。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1279145.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1141","BK1191","BK1583","03347","BK1576","03692","BK1589"],"gpt_icon":0},{"id":"2527108295","title":"翰森制药盘中异动 股价大跌3.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2527108295","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2527108295?lang=zh_cn&edition=full","pubTime":"2025-04-15 09:46","pubTimestamp":1744681603,"startTime":"0","endTime":"0","summary":"2025年04月15日早盘09时46分，翰森制药股票出现波动，股价急速下挫3.07%。截至发稿，该股报22.100港元/股，成交量156.1万股，换手率0.03%，振幅3.07%。资金方面，该股资金流入1773.33万港元，流出1314.06万港元。翰森制药股票所在的药品行业中，整体涨幅为0.17%。翰森制药公司简介：翰森制药集团有限公司是一家主要从事一系列药品的研发、生产及销售的投资控股公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250415094643aa2c6f3c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250415094643aa2c6f3c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1589","BK1191","BK1583","03692"],"gpt_icon":0},{"id":"2518211009","title":"翰森制药创新药阿美乐?获药品注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2518211009","media":"财中社","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518211009?lang=zh_cn&edition=full","pubTime":"2025-03-10 17:08","pubTimestamp":1741597724,"startTime":"0","endTime":"0","summary":"3月10日，翰森制药（03692）发布公告，宣布其创新药阿美乐?（甲磺酸阿美替尼片）获得中国国家药品监督管理局（NMPA）签发的药品注册证书，批准增加新的适应症。这一新适应症是针对经过铂类根治性放化疗后未出现疾病进展的不可切除的局部晚期非小细胞肺癌（NSCLC）患者。这是阿美乐?获批的第三项适应症。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202503103341315312.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["06978","BK1191","BK1583","BK1589","03692","BK1161","BK1574"],"gpt_icon":0},{"id":"2518215451","title":"翰森制药(03692)：阿美乐® (甲磺酸阿美替尼片)第三项适应症获国家药监局签发药品注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2518215451","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518215451?lang=zh_cn&edition=full","pubTime":"2025-03-10 16:44","pubTimestamp":1741596285,"startTime":"0","endTime":"0","summary":"智通财经APP讯，翰森制药 发布公告，集团创新药阿美乐 获中国国家药品监督管理局签发的药品注册证书，批准增加“用于含铂根治性放化疗后未出现疾病进展的不可切除的局部晚期表皮生长因子受体外显子19 缺失或外显子21置换突变的非小细胞肺癌患者的治疗”适应症。此为阿美乐获批的第三项适应症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1259760.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"翰森制药(03692)：阿美乐® (甲磺酸阿美替尼片)第三项适应症获国家药监局签发药品注册证书","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1583","BK1191","BK1589","03692"],"gpt_icon":0},{"id":"2518125763","title":"翰森制药盘中异动 股价大跌3.01%报18.660港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2518125763","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518125763?lang=zh_cn&edition=full","pubTime":"2025-03-10 10:42","pubTimestamp":1741574559,"startTime":"0","endTime":"0","summary":"2025年03月10日早盘10时42分，翰森制药股票出现波动，股价大幅跳水3.01%。截至发稿，该股报18.660港元/股，成交量315.102万股，换手率0.05%，振幅2.91%。资金方面，该股资金流入2972.09万港元，流出1945.3万港元。翰森制药股票所在的药品行业中，整体跌幅为0.17%。其相关个股中，励晶太平洋、三生制药、长江生命科技涨幅较大，振幅较大的相关个股有艾美疫苗、三生制药、德琪医药-B，振幅分别为13.32%、7.27%、7.07%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031010424098a1fd82&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031010424098a1fd82&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1589","BK1583","BK1191","03692"],"gpt_icon":0},{"id":"2517948419","title":"陕西翰森科技取得一种便于安装的防火卷帘门专利，有利于对防火卷帘门的安装","url":"https://stock-news.laohu8.com/highlight/detail?id=2517948419","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517948419?lang=zh_cn&edition=full","pubTime":"2025-03-08 15:01","pubTimestamp":1741417269,"startTime":"0","endTime":"0","summary":"金融界2025年3月8日消息，国家知识产权局信息显示，陕西翰森科技有限公司取得一项名为“一种便于安装的防火卷帘门”的专利，授权公告号 CN 222558427 U，申请日期为2024年4月。通过天眼查大数据分析，陕西翰森科技有限公司共对外投资了2家企业，参与招投标项目93次，财产线索方面有商标信息2条，专利信息10条，此外企业还拥有行政许可13个。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/03/08150148609365.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK1589","03692","BK1583","BK1191"],"gpt_icon":0},{"id":"2517970149","title":"大华继显：“确信买入”名单新增多支股票 包括吉利汽车(00175)等(表)","url":"https://stock-news.laohu8.com/highlight/detail?id=2517970149","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517970149?lang=zh_cn&edition=full","pubTime":"2025-03-06 09:50","pubTimestamp":1741225841,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，大华继显发布研报称，恒生指数和MSCI中国指数在2月份分别环比上涨13.4%和11.5%，这是受到中国科技行业乐观情绪的推动，但3月份市场可能会出现更大的波动。因此，该行将迅速实现获利了结，并且只新增估值不高的股票。该行“确信买入”名单的新增股票包括吉利汽车(00175)、京东集团-SW(09618)、新鸿基地产(00016)以及紫金矿业(02899)。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1258362.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU0971096721.USD","SG9999014005.SGD","IE0008368742.USD","LU0607220059.USD","SG9999014021.USD","LU0672654166.SGD","IE00BMCWC346.EUR","SG9999002463.SGD","LU0084288322.USD","01109","LU0821914370.USD","89618","LU1242518857.USD","LU0140636845.USD","SG9999004303.SGD","LU0043850808.USD","LU0431992006.USD","LU0630378429.USD","03692","LU2048586759.USD","LU0516422366.SGD","LU2088747998.USD","LU1880383366.USD","SG9999000459.SGD","LU1224444064.USD","LU0868486357.SGD","BK1610","LU0054237671.USD","AAGIY","01299","IE00BYV24P56.USD","EVS.SI","GELYY","LU0165289439.USD","LU0572944931.SGD","SG9999000327.SGD","00175","LU0882747503.HKD","LU0918141705.HKD","LU0797268264.HKD","LU0348814723.USD","LU0577902611.USD","LU0828238088.HKD","80175","IE00B0JY6N72.USD","81299","06690","SG9999001226.SGD"],"gpt_icon":0},{"id":"2517932669","title":"翰森制药盘中异动 急速上涨3.06%报18.860港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517932669","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517932669?lang=zh_cn&edition=full","pubTime":"2025-03-05 09:32","pubTimestamp":1741138336,"startTime":"0","endTime":"0","summary":"2025年03月05日早盘09时32分，翰森制药股票出现波动，股价大幅拉升3.06%。截至发稿，该股报18.860港元/股，成交量32.4万股，换手率0.01%，振幅3.72%。资金方面，该股资金流入362.952万港元，流出108.496万港元。翰森制药股票所在的药品行业中，整体涨幅为0.08%。其相关个股中，三生制药、翰森制药、联邦制药涨幅较大，振幅较大的相关个股有三生制药、翰森制药、联邦制药，振幅分别为4.45%、3.72%、3.37%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305093216a25fbec5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305093216a25fbec5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1583","BK1589","BK1191","03692"],"gpt_icon":0}],"profile":{"stockEarnings":[{"period":"1week","weight":0.0814},{"period":"1month","weight":0.1381},{"period":"3month","weight":0.372},{"period":"6month","weight":0.1518},{"period":"1year","weight":0.437},{"period":"ytd","weight":0.3831}],"compareEarnings":[{"period":"1week","weight":0.0274},{"period":"1month","weight":-0.064},{"period":"3month","weight":0.0954},{"period":"6month","weight":0.0675},{"period":"1year","weight":0.2717},{"period":"ytd","weight":0.0958}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"翰森制药集团有限公司是一家主要从事一系列药品的研发、生产及销售的投资控股公司。该公司的创新药产品包括阿美乐、豪森昕福、迈灵达、孚来美、恒沐、昕越、圣罗莱等产品。该公司的创新药产品主要应用于抗肿瘤、抗感染、中枢神经系统（CNS）疾病、代谢及其他治疗领域。该公司主要在国内市场开展业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.666667,"avgChangeRate":-0.014632},{"month":2,"riseRate":0.5,"avgChangeRate":0.000739},{"month":3,"riseRate":0.333333,"avgChangeRate":0.024787},{"month":4,"riseRate":0.5,"avgChangeRate":0.030666},{"month":5,"riseRate":0.6,"avgChangeRate":0.008682},{"month":6,"riseRate":0.6,"avgChangeRate":0.03658},{"month":7,"riseRate":0.5,"avgChangeRate":-0.032646},{"month":8,"riseRate":0.666667,"avgChangeRate":0.018947},{"month":9,"riseRate":0.5,"avgChangeRate":-0.03981},{"month":10,"riseRate":0.166667,"avgChangeRate":0.003801},{"month":11,"riseRate":0.666667,"avgChangeRate":0.052626},{"month":12,"riseRate":0.666667,"avgChangeRate":0.036825}],"exchange":"SEHK","name":"翰森制药","nameEN":"HANSOH PHARMA"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.33.2","shortVersion":"4.33.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"翰森制药(03692)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供翰森制药(03692)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"翰森制药,03692,翰森制药股票,翰森制药股票老虎,翰森制药股票老虎国际,翰森制药行情,翰森制药股票行情,翰森制药股价,翰森制药股市,翰森制药股票价格,翰森制药股票交易,翰森制药股票购买,翰森制药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"翰森制药(03692)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供翰森制药(03692)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}